How cells manage faulty proteins linked to diseases
Hsp40 and Hsp70 in Membrane Protein Triage
['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-11133072
This project looks at how our cells handle proteins that don't fold correctly, which can lead to serious health problems.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-11133072 on ClinicalTrials.gov |
What this research studies
Our bodies rely on proteins to work correctly, but sometimes these proteins, especially those found in cell membranes, can fold into the wrong shape. When this happens, these faulty proteins can cause diseases like cystic fibrosis, retinitis pigmentosa, and idiopathic lung fibrosis. This project aims to understand the cell's natural cleanup crew, specifically two helper proteins called Hsp40 and Hsp70, and how they identify and remove these misfolded membrane proteins. By learning how cells manage these errors, we hope to find new ways to prevent or treat these conditions.
Who could benefit from this research
Good fit: Patients with conditions caused by misfolded membrane proteins, such as cystic fibrosis, hypogonadotropic hypogonadism, retinitis pigmentosa, or idiopathic lung fibrosis, are the focus of this foundational research.
Not a fit: Patients whose conditions are not related to membrane protein misfolding or degradation mechanisms may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent the buildup of harmful proteins or help cells fix them, potentially offering new treatments for a range of genetic diseases.
How similar studies have performed: Research into chaperone proteins and protein quality control is an established field, and this project builds upon existing knowledge to explore specific mechanisms in membrane protein management.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CYR, DOUGLAS M — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: CYR, DOUGLAS M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.